Skip to main content
. Author manuscript; available in PMC: 2014 Jan 16.
Published in final edited form as: Bioconjug Chem. 2013 Jan 7;24(1):85–96. doi: 10.1021/bc300498d

Figure 3. H2009.1 tetrameric peptide liposomes display specificity for αvβ6-expressing H2009 cells compared to αvβ6-low-expressing H1299 cells.

Figure 3

Cells were incubated with different liposome formulations for 1h and liposome accumulation in cells measured using flow cytometry. A total of 10,000 cells were counted per treatment group and doxorubicin fluorescence was measured (excitation 488nm, emission 550-600nm). Representative flow cytometry analyses for H2009 cells are shown in panels a-d and for H1299 cells are shown in panels e-h. Panels d & h show the averages from 3 independent flow assays in which the mean fluorescence intensities of the H2009.1 tetrameric and scH2009.1 tetrameric liposomes were normalized to the mean fluorescence intensity of the naked liposomes.

HHS Vulnerability Disclosure